Financial reports
10-Q
2019 Q1
Quarterly report
9 May 19
10-K
2018 FY
Annual report
13 Mar 19
10-Q
2018 Q3
Quarterly report
2 Nov 18
10-Q
2018 Q2
Quarterly report
3 Aug 18
10-Q
2018 Q1
Quarterly report
4 May 18
10-K/A
2017 FY
Annual report (amended)
27 Apr 18
10-K
2017 FY
Annual report
14 Mar 18
10-Q
2017 Q3
Quarterly report
3 Nov 17
10-Q
2017 Q2
Quarterly report
4 Aug 17
10-Q
2017 Q1
Quarterly report
9 May 17
Current reports
8-K
Completion of Acquisition or Disposition of Assets
18 Jul 19
8-K
Aratana Therapeutics’ Stockholders Adopt Merger Agreement with Elanco Animal Health
16 Jul 19
8-K
Other Events
2 Jul 19
8-K
Submission of Matters to a Vote of Security Holders
7 Jun 19
8-K
Aratana Therapeutics Reports First Quarter 2019 Financial Results
8 May 19
8-K
Aratana Therapeutics to be Acquired by Elanco Animal Health
26 Apr 19
8-K
Departure of Directors or Certain Officers
15 Mar 19
8-K
Aratana Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
12 Mar 19
8-K
Departure of Directors or Certain Officers
5 Feb 19
8-K
Departure of Directors or Certain Officers
22 Jan 19
Registration and prospectus
15-12B
Securities registration termination
29 Jul 19
25-NSE
Exchange delisting
18 Jul 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Jul 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Jul 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Jul 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Jul 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Jul 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Jul 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Jul 19
POS AM
Prospectus update (post-effective amendment)
18 Jul 19
Proxies
DEFM14A
Proxy related to merger
17 Jun 19
DEFA14A
Additional proxy soliciting materials
19 Apr 19
DEF 14A
Definitive proxy
19 Apr 19
DEFA14A
Additional proxy soliciting materials
8 Jun 18
DEF 14A
Definitive proxy
8 Jun 18
DEF 14A
Definitive proxy
28 Apr 17
DEFA14A
Additional proxy soliciting materials
28 Apr 17
DEF 14A
Definitive proxy
28 Apr 16
DEFA14A
Additional proxy soliciting materials
28 Apr 16
DEF 14A
Definitive proxy
28 Apr 15
Other
EFFECT
Notice of effectiveness
22 Jul 19
EFFECT
Notice of effectiveness
22 Jul 19
UPLOAD
Letter from SEC
11 Feb 19
CORRESP
Correspondence with SEC
11 Jan 19
UPLOAD
Letter from SEC
14 Dec 18
CT ORDER
Confidential treatment order
24 Aug 18
EFFECT
Notice of effectiveness
16 Aug 17
CORRESP
Correspondence with SEC
14 Aug 17
CT ORDER
Confidential treatment order
10 Aug 17
CT ORDER
Confidential treatment order
16 Sep 16
Ownership
SC 13G
Aratana Therapeutics, Inc.
29 Jul 19
4
KEVIN KOTLER
22 Jul 19
SC 13G/A
Aratana Therapeutics, Inc.
22 Jul 19
4
WENDY L YARNO
18 Jul 19
4
Vort John Vander
18 Jul 19
4
CRAIG A TOOMAN
18 Jul 19
4
ROBERT P ROCHE JR
18 Jul 19
4
LOWELL W ROBINSON
18 Jul 19
4
CHRISTOPHER T READY
18 Jul 19
4
MERILEE RAINES
18 Jul 19